Prudential Financial’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-42,705
Closed -$268K 2561
2026
Q1
$268K Buy
42,705
+11,210
+36% +$104K ﹤0.01% 2048
2025
Q4
$386K Sell
31,495
-54,990
-64% -$899K ﹤0.01% 1913
2025
Q3
$1.77M Buy
+86,485
New +$1.37M ﹤0.01% 1408
2023
Q1
Sell
-17,200
Closed -$289K 2648
2022
Q4
$289K Sell
17,200
-895
-5% -$15.5K ﹤0.01% 2269
2022
Q3
$503K Sell
18,095
-315
-2% -$6.23K ﹤0.01% 2066
2022
Q2
$517K Sell
18,410
-85
-0.5% -$2.52K ﹤0.01% 2116
2022
Q1
$698K Sell
18,495
-255
-1% -$11.3K ﹤0.01% 2045
2021
Q4
$1.17M Buy
+18,750
New +$1.42M ﹤0.01% 1807

Other funds holding OPRX

Prudential Financial's OPRX Position: Q2 2026 in Review

Prudential Financial sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 42,705 shares — an estimated $268K sold.

Prudential Financial first reported a position in OPRX in Q4 2021 and held it in 8 quarters. The position peaked at $1.77M in Q3 2025. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Prudential Financial reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Prudential Financial sold 42,705 OptimizeRx shares in Q2 2026, an estimated $268K.
  • Prudential Financial first reported a position in OptimizeRx in Q4 2021 and held it in 8 quarters.
  • Prudential Financial's OptimizeRx position peaked at $1.77M in Q3 2025.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.